Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04144595
Other study ID # GI19-00006
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 1, 2019
Est. completion date November 30, 2019

Study information

Verified date January 2020
Source Hospital Universitario Dr. Jose E. Gonzalez
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Objective: To study the association of low maternal plasma glucose in 2 hour 75 g oral glucose tolerance test (OGTT) in women with impaired birth weight and determinate if this result is predictive of low birth weight (<10th percentile according to the INTERGROWTH-21st newborn weight standards for gestational age/sex).

Materials and methods: OGTT at 24-34 week gestation will be performed in pregnant women, the birth weight will be compared between women with low fasting plasma glucose (FPG) (<10th percentile, <65 mg/dL) and normal FPG (≥10th percentile, ≥ 65 mg/dL) also for 1 and 2-hour plasma glucose (1-h PG/2-h PG). Receiver operating characteristic curve analysis will be used to determine the optimal lower OGTT threshold for the prediction of low birth weight.


Description:

Maternal hypoglycemia has been reported to be linked with low birth weight and poor neonatal outcome. OGTT is performed routinely in pregnancy and hypoglycemia following this screening test is often encountered and the implication of this finding for the fetal growth is unclear.

The aim of study will be determinate the association of low maternal plasma glucose in OGTT in women with impaired birth weight and determinate if this result is predictive of low birth weight (<10th percentile according to the INTERGROWTH-21st newborn weight standards for gestational age/sex).

The study population will consist of patients with singleton pregnancies who will undergo OGTT at 24-34 weeks, have regular medical checkups throughout their entire pregnancy, deliver on or after 25 week gestation and fulfill inclusion criteria.

The birth weight will be compared between women with low fasting plasma glucose (FPG) (<10th percentile, <65 mg/dL*) and normal FPG (≥10th percentile, ≥ 65 mg/dL) also for 1 and 2-hour plasma glucose (1-h PG/2-h PG). Receiver operating characteristic curve analysis will be used to determine the optimal lower OGTT threshold for the prediction of low birth weight.

This study will be performed according to the standards of the Helsinki Declaration and approval was obtained from the ethics and educational issues coordinating committee of our University Hospital.

*Determinated previously in a pilot study


Recruitment information / eligibility

Status Completed
Enrollment 300
Est. completion date November 30, 2019
Est. primary completion date October 28, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group N/A and older
Eligibility Inclusion Criteria:

- Women with singleton pregnancy who underwent OGTT at 24-34 weeks and had regular medical checkups throughout their entire pregnancy.

- Gestational age was determined based on the last menstrual period. If gestational age according to the last menstrual period differed by more than 7 days from that according to ultrasonography at <11 weeks, the latter was used to assign gestational age.

Exclusion Criteria:

- Inaccurate gestational age

- OGTT being drawn outside the prescribed window of 24 to 34 weeks gestation.

- Patients who could not swallow the OGTT solution or vomited afterward were excluded from the study.

- Patients who were diagnosed with gestational diabetes at any time during their pregnancy were excluded.

- The following comorbidities or complications that could affect fetal growth also were excluded: cardiac disease, preeclampsia, gestational hypertension, tobacco use, alcohol intake, stimulant drugs use, maternal systemic diseases (e.g., hypertension, pregestational diabetes, autoimmune disease, thrombotic disease, thyroid disease), intrauterine infectious diseases (e.g., cytomegalovirus, rubella, toxoplasmosis, syphilis), major neonatal anomalies or genetic and structural disorders (e.g., trisomy 21, trisomy 18, trisomy 13, congenital heart disease), placental disorders, and umbilical cord abnormalities.

- Patients with high risk for preeclampsia, intrauterine growth restriction, trisomy 21, trisomy 18 and trisomy 13 in the first trimester screening test.

- Patients with incomplete or missing data were also excluded.

Study Design


Intervention

Diagnostic Test:
2 hour 75 g Oral glucose tolerance test
In pregnant women between 24 and 34 weeks of gestational age, plasma glucose was recorded after an overnight fast. Following consumption of 75 g glucose in 200 mL water over 10 min, the equivalent 1 hour and 2 hour values was recorded

Locations

Country Name City State
Mexico Hospital Universitario Dr. José Eleuterio González Monterrey Nuevo León

Sponsors (1)

Lead Sponsor Collaborator
Hospital Universitario Dr. Jose E. Gonzalez

Country where clinical trial is conducted

Mexico, 

References & Publications (8)

Feinberg JH, Magann EF, Morrison JC, Holman JR, Polizzotto MJ. Does maternal hypoglycemia during screening glucose assessment identify a pregnancy at-risk for adverse perinatal outcome? J Perinatol. 2005 Aug;25(8):509-13. — View Citation

Leng J, Hay J, Liu G, Zhang J, Wang J, Liu H, Yang X, Liu J. Small-for-gestational age and its association with maternal blood glucose, body mass index and stature: a perinatal cohort study among Chinese women. BMJ Open. 2016 Sep 15;6(9):e010984. doi: 10. — View Citation

Melamed N, Hiersch L, Peled Y, Hod M, Wiznitzer A, Yogev Y. The association between low 50 g glucose challenge test result and fetal growth restriction. J Matern Fetal Neonatal Med. 2013 Jul;26(11):1107-11. doi: 10.3109/14767058.2013.770460. Epub 2013 Feb — View Citation

Nayak AU, Vijay AMA, Indusekhar R, Kalidindi S, Katreddy VM, Varadhan L. Association of hypoglycaemia in screening oral glucose tolerance test in pregnancy with low birth weight fetus. World J Diabetes. 2019 May 15;10(5):304-310. doi: 10.4239/wjd.v10.i5.3 — View Citation

Rogne T, Jacobsen GW. Association between low blood glucose increase during glucose tolerance tests in pregnancy and impaired fetal growth. Acta Obstet Gynecol Scand. 2014 Nov;93(11):1160-9. doi: 10.1111/aogs.12365. Epub 2014 Mar 26. — View Citation

Shinohara S, Uchida Y, Hirai M, Hirata S, Suzuki K. Relationship between maternal hypoglycaemia and small-for-gestational-age infants according to maternal weight status: a retrospective cohort study in two hospitals. BMJ Open. 2016 Dec 2;6(12):e013749. d — View Citation

Topçu HO, Iskender CT, Çelen S, Oskovi A, Uygur D, Erkaya S. Maternal hypoglycemia on 50 g glucose challenge test: outcomes are influenced by fetal gender. J Perinat Med. 2016 May 1;44(4):369-76. doi: 10.1515/jpm-2015-0060. — View Citation

Vadakekut ES, McCoy SJ, Payton ME. Association of maternal hypoglycemia with low birth weight and low placental weight: a retrospective investigation. J Am Osteopath Assoc. 2011 Mar;111(3):148-52. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Birth weight <10th percentile Birth weight <10th percentile according to the INTERGROWTH-21st newborn weight standards for gestational age/sex. Newborn birth weight delivered on or after 25 week gestation will be recorded within the first hour after delivery
Primary Birthweight <3th percentile Birthweight <3th percentile according to the INTERGROWTH-21st newborn weight standards for gestational age/sex. Newborn birth weight delivered on or after 25 week gestation will be recorded within the first hour after delivery
Primary Birth weight <2500 g Birth weight <2500 g of newborn delivered on or after 37 week gestation Newborn birth weight delivered on or after 37 week gestation will be recorded within the first hour after delivery
See also
  Status Clinical Trial Phase
Completed NCT01163188 - Social Adjustment and Quality of Life After Very Preterm Birth N/A
Completed NCT03533712 - Effect of a Fortified Balanced Energy-Protein Supplement on Birth Outcome and Child Growth in Houndé District, Burkina Faso. Phase 4
Completed NCT01461863 - DarDar Nutrition Study in HIV Breastfeeding Women N/A
Terminated NCT00607061 - Synthesis of Glutathione From Low Birth Weight Newborn Babies N/A
Recruiting NCT05576207 - BEP Supplementation Research in Bangladesh (JiVitA-BEP-IR) N/A
Completed NCT03112018 - Strengthening Facility-based Intrapartum/Immediate Newborn Care to Reduce Mortality of Preterm Infants in Migori County, Kenya and Busoga Region, Uganda N/A
Completed NCT05515211 - Diagnostic Accuracy of Foot Length in Predicting Preterm and Low Birth Weight Using Ultrasound Dating as The Gold Standard in a Rural District of Pakistan
Completed NCT02631343 - Community Kangaroo Mother Care for Improving Child Survival and Brain Development in Low Birth Weight Newborns N/A
Completed NCT00971815 - Effects of 3 Months of Selective Serotonin Reuptake Inhibitor (SSRI)-Treatment on Metabolism and Hypothalamic-pituitary-adrenal (HPA)-Axis in Young Men Born With Low Birth Weight N/A
Terminated NCT02090088 - Nplate® Pregnancy Exposure Registry N/A
Completed NCT03154177 - Group Antenatal/Postnatal Care in Rwanda N/A
Withdrawn NCT00582374 - Periodontal Disease and Preterm Birth N/A
Completed NCT00925925 - Epigenetic Markers of B-Cell Function in Low Birth Weight Infants N/A
Completed NCT03506698 - Kangaroo Mother Care Implementation Research for Accelerating Scale-up
Completed NCT04908332 - Effect of Kangaroo Baby Massage on Mother-infant Interaction at Home N/A
Completed NCT01115478 - Malaria in Pregnancy: Nutrition and Immunologic Effects N/A
Completed NCT00702767 - Tolerance of Increased Infusion Rates of Intravenous Fat Emulsions in Very Low Birth Weight Infants N/A
Recruiting NCT05730569 - Description and Comparison of Biological Vulnerability in Small Vulnerable Newborns Versus Healthy Community Controls in Urban Burkina Faso
Completed NCT01487980 - Effect of Delayed Cord Clamping on Haematological Status in Low Birth Weight Infants N/A
Completed NCT01235767 - Animal Source Food Supplement and Pregnancy in Vietnam N/A